| Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study HU Ahmed, AES Bosaily, LC Brown, R Gabe, R Kaplan, MK Parmar, ... The Lancet 389 (10071), 815-822, 2017 | 3002 | 2017 |
| PROMIS—prostate MR imaging study: a paired validating cohort study evaluating the role of multi-parametric MRI in men with clinical suspicion of prostate cancer AES Bosaily, C Parker, LC Brown, R Gabe, RG Hindley, R Kaplan, ... Contemporary clinical trials 42, 26-40, 2015 | 127 | 2015 |
| Multiparametric MRI to improve detection of prostate cancer compared with transrectal ultrasound-guided prostate biopsy alone: the PROMIS study. LC Brown, HU Ahmed, R Faria, AES Bosaily, R Gabe, RS Kaplan, ... Health technology assessment (Winchester, England) 22 (39), 1, 2018 | 113 | 2018 |
| What type of prostate cancer is systematically overlooked by multiparametric magnetic resonance imaging? An analysis from the PROMIS cohort JM Norris, LMC Echeverria, SRJ Bott, LC Brown, N Burns-Cox, ... European urology 78 (2), 163-170, 2020 | 81 | 2020 |
| Additional value of dynamic contrast-enhanced sequences in multiparametric prostate magnetic resonance imaging: data from the PROMIS study AES Bosaily, E Frangou, HU Ahmed, M Emberton, S Punwani, R Kaplan, ... European urology 78 (4), 503-511, 2020 | 40 | 2020 |
| The PROMIS study: A paired-cohort, blinded confirmatory study evaluating the accuracy of multi-parametric MRI and TRUS biopsy in men with an elevated PSA. HU Ahmed, A El-Shater Bosaily, LC Brown, RS Kaplan, Y Colaco-Moraes, ... Journal of Clinical Oncology 34 (15_suppl), 5000-5000, 2016 | 28 | 2016 |
| False positive multiparametric magnetic resonance imaging phenotypes in the biopsy-naïve prostate: are they distinct from significant cancer-associated lesions? Lessons from PROMIS V Stavrinides, T Syer, Y Hu, F Giganti, A Freeman, S Karapanagiotis, ... European urology 79 (1), 20-29, 2021 | 22 | 2021 |
| Beyond transrectal ultrasound-guided prostate biopsies: available techniques and approaches C Warlick, J Futterer, M Maruf, AK George, AR Rastinehad, PA Pinto, ... World Journal of Urology 37, 419-427, 2019 | 15 | 2019 |
| Comparison of transrectal ultrasound biopsy to transperineal template mapping biopsies stratified by multiparametric magnetic resonance imaging score in the PROMIS trial CE Lovegrove, S Miah, A El-Shater Bosaily, S Bott, L Brown, N Burns-Cox, ... The Journal of Urology 203 (1), 100-107, 2020 | 14 | 2020 |
| The concordance between the volume hotspot and the grade hotspot: a 3-D reconstructive model using the pathology outputs from the PROMIS trial A El-Shater Bosaily, M Valerio, Y Hu, A Freeman, C Jameson, L Brown, ... Prostate cancer and prostatic diseases 19 (3), 258-263, 2016 | 13* | 2016 |
| Defining the level of evidence for technology adoption in the localized prostate cancer pathway M Valerio, AES Bosaily, M Emberton, HU Ahmed Urologic Oncology: Seminars and Original Investigations 32 (6), 924-930, 2014 | 8 | 2014 |
| Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study PROMIS study group A El-Shater Bosaily, LC Brown, R Gabe, R Kaplan, MK Parmar, ... The Lancet 389 (10071), 815-822, 2017 | 6 | 2017 |
| Re: Multiparametric magnetic resonance imaging guided diagnostic biopsy detects significant prostate cancer and could reduce unnecessary biopsies and over detection: a … AES Bosaily, M Arya, S Punwani, M Emberton, A Kirkham, A Freeman, ... The Journal of urology 193 (2), 735-736, 2015 | 6 | 2015 |
| A critical evaluation of visual proportion of Gleason 4 and maximum cancer core length quantified by histopathologists LM Carmona Echeverria, A Haider, A Freeman, U Stopka-Farooqui, ... Scientific Reports 10 (1), 17177, 2020 | 5 | 2020 |
| MP81-19 WHICH PROSTATE CANCERS ARE OVERLOOKED BY MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING? AN ANALYSIS FROM PROMIS J Norris*, LC Echeverria, S Bott, L Brown, L Brown, N Burns-Cox, ... The Journal of Urology 203 (Supplement 4), e1243-e1244, 2020 | 4 | 2020 |
| MP38-07 Should we aim for the centre of an MRI prostate lesion? Correlation between mpMRI and 3-Dimensional 5mm transperineal prostate mapping biopsies from the PROMIS trial C Orczyk, YP Hu, E Gibson, A El-Shater Bosaily, A Kirkham, S Punwani, ... The Journal of Urology 197 (4S), e486-e486, 2017 | 4 | 2017 |
| Clinical predictors of survival in men with castration-resistant prostate cancer: evidence that Gleason score 6 cancer can evolve to lethal disease. M Arya, H Ahmed Cancer 119 (22), 4052-4053, 2013 | 3 | 2013 |
| Regional histopathology and prostate MRI positivity: a secondary analysis of the PROMIS trial V Stavrinides, JM Norris, S Karapanagiotis, F Giganti, A Grey, N Trahearn, ... Radiology 307 (1), e220762, 2022 | 2 | 2022 |
| Multiparametric MRI approach to prostate cancer with a pictorial essay on PI-RADS PB Popat, S Maheshwari, NP Sable, M Thakur, A Katdare Journal of Gastrointestinal and Abdominal Radiology 2 (01), 004-017, 2019 | 2 | 2019 |
| The University College London/Medical Research Council/National Institute of Health Research-Health Technology Assessment PROMIS Trial: An Update AES Bosaily, C Parker, LC Brown, R Gabe, RG Hindley, R Kaplan, ... European Urology Focus 1 (2), 212-214, 2015 | 1 | 2015 |
